United Therapeutics Corporation Cash Flow-to-Debt Ratio
United Therapeutics Corporation cash flow-to-debt ratio. United Therapeutics Corporation (UTHR) has a Cash Flow-to-Debt Ratio of 0.38x as of June 2026, meaning its operating cash flow of $313.60 Million could theoretically repay 0% of its total liabilities ($819.80 Million) in one year. Check United Therapeutics Corporation earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of United Therapeutics Corporation (1998–2025)
Cash flow-to-debt ratio of United Therapeutics Corporation from 1998 to 2025. Historical debt coverage capacity for United Therapeutics Corporation across 28 annual periods. Check how aggressively does United Therapeutics Corporation reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
United Therapeutics Corporation Cash Flow-to-Debt Ratio by Year (1998–2025)
United Therapeutics Corporation cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for United Therapeutics Corporation. For the full cash flow conversion analysis, see United Therapeutics Corporation cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.99x | $1.56 Billion | $783.80 Million | ▲ +38.1% |
| 2024 | 1.44x | $1.33 Billion | $920.00 Million | ▲ +74.4% |
| 2023 | 0.83x | $978.00 Million | $1.18 Billion | ▲ +28.6% |
| 2022 | 0.64x | $802.50 Million | $1.25 Billion | ▲ +30.1% |
| 2021 | 0.49x | $598.20 Million | $1.21 Billion | ▼ -20.2% |
| 2020 | 0.62x | $755.70 Million | $1.22 Billion | ▲ +439.8% |
| 2019 | -0.18x | $-206.60 Million | $1.13 Billion | ▼ -114.3% |
| 2018 | 1.27x | $778.40 Million | $612.40 Million | ▲ +108.4% |
| 2017 | 0.61x | $474.20 Million | $777.60 Million | ▼ -56.1% |
| 2016 | 1.39x | $643.60 Million | $463.40 Million | ▲ +112.2% |
| 2015 | 0.65x | $382.80 Million | $584.80 Million | ▲ +14.0% |
| 2014 | 0.57x | $355.30 Million | $618.84 Million | ▲ +5.7% |
| 2013 | 0.54x | $425.27 Million | $783.26 Million | ▼ -10.8% |
| 2012 | 0.61x | $323.63 Million | $531.73 Million | ▲ +38.6% |
| 2011 | 0.44x | $250.19 Million | $569.59 Million | ▲ +13.7% |
| 2010 | 0.39x | $211.53 Million | $547.75 Million | ▲ +54.3% |
| 2009 | 0.25x | $99.72 Million | $398.54 Million | ▲ +285.0% |
| 2008 | -0.14x | $-49.20 Million | $363.62 Million | ▼ -180.5% |
| 2007 | 0.17x | $48.95 Million | $291.23 Million | ▼ -6.8% |
| 2006 | 0.18x | $49.39 Million | $273.94 Million | ▼ -93.2% |
| 2005 | 2.65x | $43.17 Million | $16.31 Million | ▲ +97.7% |
| 2004 | 1.34x | $20.78 Million | $15.52 Million | ▲ +283.5% |
| 2003 | -0.73x | $-8.56 Million | $11.74 Million | ▲ +57.7% |
| 2002 | -1.72x | $-22.26 Million | $12.91 Million | ▲ +30.3% |
| 2001 | -2.47x | $-38.90 Million | $15.72 Million | ▼ -26.5% |
| 2000 | -1.96x | $-31.11 Million | $15.91 Million | ▲ +48.0% |
| 1999 | -3.76x | $-23.70 Million | $6.30 Million | ▲ +21.6% |
| 1998 | -4.80x | $-9.60 Million | $2.00 Million | — |